Concepedia
Statistics
Publications
14
Citations
1.2K
H-Index
13
Active since
1993
Affiliations
Boehringer Ingelheim (Germany)(Current)
McMaster University
Centre Léon Bérard
European Institute of Oncology
University of Alabama
Michael Merger is an author at Boehringer Ingelheim (Germany) specializing in medicine, cell signaling, and pathology.
Top concepts
MedicineUrologyOncologyPathologyImmunologyPhysiologyAutoimmunityCell BiologyInflammationPharmacology
Publications per year
1993–2019
Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities
Phillip D. Smith, Lesley E. Smythies, Meg Mosteller‐Barnum et al. · The Journal of Immunology · 2001 · 322 citations · Full text
Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer
Jonathan A. Ledermann, Allan Hackshaw, Stan Kaye et al. · Journal of Clinical Oncology · 2011 · 214 citations
Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine
Alexander Gebauer, Michael Merger, H. Kilbinger · Naunyn-Schmiedeberg s Archives of Pharmacology · 1993 · 130 citations
Guinea-pig Small Intestine, Neuropeptides, Medicine +7
Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine
Michael Merger, Joanne L. Viney, Rajka Borojevic et al. · Gut · 2002 · 102 citations · Full text
Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine
Phillip D. Smith, Edward N. Janoff, Meg Mosteller-Barnum et al. · Journal of Immunological Methods · 1997 · 97 citations
Inflammation, Cd14-negative Mucosal Macrophages, Autoimmune Disease +8
1–5 of 14